Mostrar el registro sencillo del ítem

Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry

dc.contributor.authorKapelios, C.J.*
dc.contributor.authorBenson, L.*
dc.contributor.authorCrespo Leiro, Marisa *
dc.contributor.authorAnker, S.D.*
dc.contributor.authorCoats, A.J.S.*
dc.contributor.authorChioncel, O.*
dc.contributor.authorFilippatos, G.*
dc.contributor.authorLainscak, M.*
dc.contributor.authorMcDonagh, T.*
dc.contributor.authorMebazaa, A.*
dc.contributor.authorMetra, M.*
dc.contributor.authorPiepoli, M.F.*
dc.contributor.authorRosano, G.M.C.*
dc.contributor.authorRuschitzka, F.*
dc.contributor.authorSavarese, G.*
dc.contributor.authorSeferovic, P.M.*
dc.contributor.authorVolterrani, M.*
dc.contributor.authorMaggioni, A.P.*
dc.contributor.authorLund, L.H.*
dc.date.accessioned2025-09-12T11:49:27Z
dc.date.available2025-09-12T11:49:27Z
dc.date.issued2023
dc.identifier.citationKapelios CJ, Benson L, Crespo-Leiro MG, Anker SD, Coats AJS, Chioncel O, et al. Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry. European Heart Journal. 2023;44(17):1526-9.
dc.identifier.issn1522-9645
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/648600d6a219857f1d78956c
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21832
dc.description.sponsorshipSince the start of EORP, the following companies have supported the programme: Abbott Vascular Int. (2011-21), Amgen (2009-18), AstraZeneca(2014-21), Bayer (2009-18), Boehringer Ingelheim (2009-19), BostonScientific (2009-12), The Bristol-Myers Squibb and Pfizer Alliance (2011-19), Daiichi-Sankyo Europe (2011-20), The Alliance Daiichi-SankyoEurope GmbH and Eli Lilly and Company (2014-17), Edwards (2016-19),Gedeon Richter Plc. (2014-16), Fondazione Internazionale Menarini(2009-12), MSD (2011-14), Novartis Pharma AG (2014-20), ResMed (2014-16), Sanofi(2009-11), Servier (2009-21), Vifor (2019-22). L.H.L. is supported by Karolinska Institutet, the Swedish Research Council (grant 523-2014-2336), the Swedish Heart Lung Foundation (grants 20150557, 20190310), and the Stockholm County Council (grants 20170112 and 20190525)
dc.languageeng
dc.rightsAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.meshHumans *
dc.subject.meshHeart Failure *
dc.subject.meshStroke Volume *
dc.subject.meshHospitalization *
dc.subject.meshRegistries *
dc.subject.meshVentricular Function, Left *
dc.titleParticipation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
dc.typeArtigo
dc.authorsophosKapelios, C.J.; Benson, L.; Crespo-Leiro, M.G.; Anker, S.D.; Coats, A.J.S.; Chioncel, O.; Filippatos, G.; Lainscak, M.; McDonagh, T.; Mebazaa, A.; Metra, M.; Piepoli, M.F.; Rosano, G.M.C.; Ruschitzka, F.; Savarese, G.; Seferovic, P.M.; Volterrani, M.; Maggioni, A.P.; Lund, L.H.
dc.identifier.doi10.1093/eurheartj/ehad109
dc.identifier.sophos648600d6a219857f1d78956c
dc.issue.number17
dc.journal.titleEuropean Heart Journal*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Cardioloxía
dc.page.initial1526
dc.page.final1529
dc.relation.projectIDAbbott Vascular Int.
dc.relation.projectIDAmgen
dc.relation.projectIDAstraZeneca
dc.relation.projectIDBayer
dc.relation.projectIDBoehringer Ingelheim
dc.relation.projectIDBostonScientific
dc.relation.projectIDBristol-Myers Squibb
dc.relation.projectIDPfizer Alliance
dc.relation.projectIDDaiichi-Sankyo Europe
dc.relation.projectIDAlliance Daiichi-SankyoEurope GmbH
dc.relation.projectIDEli Lilly and Company
dc.relation.projectIDEdwards
dc.relation.projectIDGedeon Richter Plc.
dc.relation.projectIDFondazione Internazionale Menarini
dc.relation.projectIDMSD
dc.relation.projectIDNovartis Pharma AG
dc.relation.projectIDResMed
dc.relation.projectIDSanofi
dc.relation.projectIDServier
dc.relation.projectIDVifor
dc.relation.projectIDKarolinska Institutet
dc.relation.projectIDSwedish Research Council [523-2014-2336]
dc.relation.projectIDSwedish Heart Lung Foundation [20150557, 20190310]
dc.relation.projectIDStockholm County Council [20170112, 20190525]
dc.relation.projectIDSwedish Heart-Lung Foundation [20190525] Funding Source: Swedish Heart-Lung Foundation
dc.relation.publisherversionhttps://doi.org/10.1093/eurheartj/ehad109
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.typefidesArtículo de Opinión (Editorial, Carta, ?)
dc.typesophosArtículo de Opinión
dc.volume.number44


Ficheros en el ítem

Descargar/
Nombre:
2160.pdf
Tamaño:
277.5Kb
Formato:
PDF
Descripción:
Kapelios CJ, Benson L, Crespo-Leiro MG, Anker SD, Coats AJS, Chioncel O, et al. ...

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)